Published in Addict Behav on February 02, 2001
Delayed reward discounting predicts treatment response for heavy drinkers receiving smoking cessation treatment. Drug Alcohol Depend (2009) 2.01
Anxiety, depression, and cigarette smoking: a transdiagnostic vulnerability framework to understanding emotion-smoking comorbidity. Psychol Bull (2014) 1.25
Sensation seeking as a predictor of treatment compliance and smoking cessation treatment outcomes in heavy social drinkers. Pharmacol Biochem Behav (2009) 1.04
Novelty Seeking and Drug Addiction in Humans and Animals: From Behavior to Molecules. J Neuroimmune Pharmacol (2015) 0.84
Targeting nicotine addiction: the possibility of a therapeutic vaccine. Drug Des Devel Ther (2011) 0.82
Effects of 24 hours of tobacco withdrawal and subsequent tobacco smoking among low and high sensation seekers. Nicotine Tob Res (2011) 0.82
Sensation seeking as a potential screening tool for suicidality in adolescence. BMC Public Health (2016) 0.75
Waterpipe Smoking And The DRD2/ANKK1 Genotype. J Egypt Public Health Assoc (2010) 0.75
Early and late onset bipolar disorders: two different forms of manic-depressive illness? J Affect Disord (2000) 1.71
Psychiatric genetics: search for phenotypes. Trends Neurosci (1998) 1.68
Psychometric normalization of a hyperacusis questionnaire. ORL J Otorhinolaryngol Relat Spec (2002) 1.51
WHO Europe evidence based recommendations on the treatment of tobacco dependence. Tob Control (2002) 1.51
Low-dose angiotensin-converting-enzyme inhibitor captopril to reduce proteinuria in adult idiopathic membranous nephropathy: a prospective study of long-term treatment. Nephrol Dial Transplant (1995) 1.49
Sleep effects of a 24-h versus a 16-h nicotine patch: a polysomnographic study during smoking cessation. Sleep Med (2006) 1.44
[Effect of smoking on the fetus and the child during pregnancy]. J Gynecol Obstet Biol Reprod (Paris) (1995) 1.39
A vascular permeability factor elaborated from lymphocytes. I. Demonstration in patients with nephrotic syndrome. Biomedicine (1975) 1.39
Efficacy and specificity of computer-assisted cognitive remediation in schizophrenia: a meta-analytical study. Psychol Med (2010) 1.37
Body image perception among men in three countries. Am J Psychiatry (2000) 1.24
Decreased presynaptic dopamine function in the left caudate of depressed patients with affective flattening and psychomotor retardation. Am J Psychiatry (2001) 1.22
Altered C1 inhibitor genes in type I hereditary angioedema. N Engl J Med (1987) 1.19
[Diagnosis of drug allergy "in vitro" by use of the lymphoblastic transformation test (LTT)]. Presse Med (1967) 1.13
Antidepressant effect of salbutamol. Lancet (1977) 1.10
The dimensional approach to clinical psychopharmacology: a polysemous concept. J Psychiatry Neurosci (1992) 1.10
Efficacy of bupropion and predictors of successful outcome in a sample of French smokers: a randomized placebo-controlled trial. Addiction (2004) 1.09
[A new approach to the treatment of depression: salbutamol]. Ann Med Interne (Paris) (1978) 1.07
Chronic high dose transdermal nicotine in Parkinson's disease: an open trial. Eur J Neurol (2007) 1.06
Affective disturbances in Alzheimer's disease. J Am Geriatr Soc (1996) 1.06
Analysis of glomerular complement receptors in various types of glomerulonephritis. Clin Immunol Immunopathol (1976) 1.04
Sensation seeking, nicotine dependence, and smoking motivation in female and male smokers. Addict Behav (1994) 1.03
Impaired IgG synthesis in patients with the nephrotic syndrome. Clin Nephrol (1982) 1.02
High-dose immunoglobulin therapy for severe IgA nephropathy and Henoch-Schönlein purpura. Ann Intern Med (1994) 1.02
Alexithymia and anxiety: compounded relationships? A psychometric study. Eur Psychiatry (1999) 1.02
Letter: Lymphokines and nephrotic syndrome. Lancet (1975) 1.01
Cognitive function in recent-onset demyelinating diseases. Arch Neurol (1986) 1.01
[Proteinuria and loaiasis. Histologic, optic and electronic study of a case]. Bull Mem Soc Med Hop Paris (1967) 1.00
[Primary glomerulopathy with IgA and IgG mesangial deposits. Clinical and morphological study of 52 cases]. Presse Med (1970) 1.00
Transfer of learning across durations and ears in auditory frequency discrimination. Percept Psychophys (2002) 0.99
[Serum complement in human kidney diseases]. Pathol Biol (1967) 0.98
[Complementuria in human glomerulopathies]. Rev Fr Etud Clin Biol (1969) 0.97
[Identifying addictive behaviors among adolescents: a school-based survey]. Arch Pediatr (2011) 0.96
Intravenous methylprednisolone pulses in diffuse proliferative lupus nephritis. Lancet (1977) 0.94
Psychopathological and emotional deficits in myotonic dystrophy. J Neurol Neurosurg Psychiatry (1998) 0.93
[So-called immunodepressive chemotherapy in primary nephrotic syndromes in children]. Presse Med (1967) 0.93
Vascular hyperpermeability in nephrotic edema. Nephron (2000) 0.92
Allergy and lipoid nephrosis. Adv Nephrol Necker Hosp (1983) 0.92
In vitro effects of nicotine on mitochondrial respiration and superoxide anion generation. Brain Res (2001) 0.92
The Temperament and Character Inventory-Revised (TCI-R): psychometric characteristics of the French version. Acta Psychiatr Scand (2005) 0.92
A beta adrenergic stimulant (salbutamol) versus clomipramine in depression: a controlled study. Br J Psychiatry (1980) 0.92
Pigeon's eyes converge during feeding: evidence for frontal binocular fixation in a lateral-eyed bird. Neurosci Lett (1984) 0.91
[Primary glomerular disease associated with inhaled organic solvants (author's transl)]. Nouv Presse Med (1977) 0.91
Smoking cessation guidelines: evidence-based recommendations of the French Health Products Safety Agency. Eur Psychiatry (2005) 0.91
Clinical and neurochemical effect of acute tryptophan depletion in unaffected relatives of patients with bipolar affective disorder. Biol Psychiatry (2001) 0.91
The vascular permeability factor is a T lymphocyte product. Nephron (1986) 0.90
Chromium concentration by proximal renal tubule cells: an ultrastructural, microanalytical and cytochemical study. J Histochem Cytochem (1978) 0.90
An increase in circulating IgA antibodies to gliadin in IgA mesangial glomerulonephritis. Am J Nephrol (1987) 0.90
Differentiation between vascular permeability factor and IL-2 in lymphocyte supernatants from patients with minimal-change nephrotic syndrome. Clin Exp Immunol (1991) 0.89
[Mückle-Wells syndrome. 5th familial case]. Nouv Presse Med (1972) 0.89
A study of posttraumatic disorders in children who experienced an industrial disaster in the Briey region. Eur Child Adolesc Psychiatry (2001) 0.89
Lack of startle modulation by smoking cues in smokers. Psychopharmacology (Berl) (2004) 0.89
Antiproteinuric effect of captopril in primary glomerular disease. Nephron (1987) 0.88
[Measurements of serum C3d in primitive chronic glomerular nephropathies (author's transl)]. Nouv Presse Med (1979) 0.88
Basophil sensitisation in idiopathic nephrotic syndrome. Lancet (1982) 0.87
Sensation-seeking and emotional disturbances in depression: relationships and evolution. J Affect Disord (1995) 0.87
Relationships between the emotional and cognitive components of alexithymia and dependency in alcoholics. Psychiatry Res (2000) 0.86
Sex, lies and virtual reality. Nat Neurosci (1998) 0.85
Presence of antibodies against endothelial cells in the sera of patients with episodic angioedema and hypereosinophilia. Clin Exp Immunol (1990) 0.85
[Proceedings: Mesangial glomerulonephritis with IgA deposits: study of serum immunoglobulins]. J Urol Nephrol (Paris) (1975) 0.85
[Usefulness of biological markers in evaluation of smoking]. Pathol Biol (Paris) (2004) 0.85
High levels of IgA antigliadin antibodies in patients who have IgA mesangial glomerulonephritis but not coeliac disease. Lancet (1988) 0.85
["Extra-membranous" glomerulopathies (E.M.G.). Morphological study with optic microscopy, electron microscopy and immunofluorescence]. Pathol Biol (Paris) (1970) 0.85
Idiopathic edema. Lancet (1979) 0.85
Seronegative spondyloarthropathies and IgA glomerulonephritis: a report of four cases and a review of the literature. Semin Arthritis Rheum (1986) 0.85
Directed forgetting in PTSD: a comparative study versus normal controls. J Psychiatr Res (2006) 0.85
Tobacco smoking induces expression of very-high-affinity nicotine binding sites on blood polymorphonuclear cells. Am J Respir Crit Care Med (1996) 0.84
Serum IgE in primary glomerular diseases. Nephron (1984) 0.84
Secretory IgA are elevated in both saliva and serum of patients with various types of primary glomerulonephritis. Clin Exp Immunol (1992) 0.84
[Detection of circulating immune complexes by the C1q complement fraction deviation test. 1st application in the study of human glomerulopathies]. Nouv Presse Med (1976) 0.84
Long-term cyclosporin A therapy for severe idiopathic membranous nephropathy. Nephron (1993) 0.83
Prevalence of DSM-IV disorders in children and adolescents with asthma versus diabetes. Can J Psychiatry (1999) 0.83
[The immuno-depressive agents in nephrology. Trial treatments of chronic primary glomerular diseases]. Presse Med (1967) 0.83
[Cutaneous microvascular flow studied by laser-Doppler. A study of 100 healthy volunteers]. Presse Med (1991) 0.83
Frontal reactivity and sensation seeking an ERP study in skydivers. Prog Neuropsychopharmacol Biol Psychiatry (1999) 0.83
Food allergy in idiopathic nephrotic syndrome. Lancet (1987) 0.83
IgA nephropathy associated with seronegative spondylarthropathies: efficacy on non steroidal anti-inflammatory drugs (NSAIDs) Clin Nephrol (1985) 0.83
[Determination of the fractions of complement (C'1, C'2, C'3, C'4) in hypocomplimentary glomerulopathies]. Rev Fr Etud Clin Biol (1967) 0.82
Apolipoprotein E gene polymorphism in early and late onset bipolar patients. Neurosci Lett (1997) 0.82
Focal glomerulosclerosis associated with Charcot-Marie-Tooth disease. Nephron (1985) 0.82
[Parietoproliferative glomerulonephritis--(P.P.G.N.). Histopathological study under optic and electron microscopy and with immunochemistry of 49 cases. Anatomo-clinical correlations]. Pathol Biol (Paris) (1971) 0.82
Balance control and posture in anxious mice improved by SSRI treatment. Neuroreport (2001) 0.82
Quantitation of C2 by rocket immunoelectrophoresis in 120 pathological sera. Pathol Biol (Paris) (1981) 0.82
IgA antigliadin antibodies as a possible marker for IgA mesangial glomerulonephritis in adults with primary glomerulonephritis. N Engl J Med (1989) 0.82
[Recovery of normal ultrastructure in 2 cases of primary glomerulonephritis with diffuse extra-membranous deposits]. Presse Med (1968) 0.82
[Cyclic idiopathic edema syndrome. I. Clinical study]. J Urol Nephrol (Paris) (1971) 0.81
Dietary manipulation for idiopathic nephrotic syndrome. A new approach to therapy. Allergy (1989) 0.81
Serum IgG subclasses and IgM imbalances in adult IgA mesangial glomerulonephritis and idiopathic Henoch-Schoenlein purpura. Clin Exp Immunol (1989) 0.81
Early emotional disturbances during nicotine patch therapy in subjects with and without a history of depression. J Affect Disord (2002) 0.81
Mucosal immunity in adult primary glomerulonephritis. I. Evaluation of salivary IgA subclasses and components. Nephron (1990) 0.81
[The Pleasure-Displeasure Scale. Use in the evaluation of depressive illness]. Encephale (1987) 0.81
The effects of chronic renal insufficiency on the pharmacokinetics of doxycycline in man. Br J Clin Pharmacol (1983) 0.81
Adaptation as a sensorial profile in trait anxiety: a study with virtual reality. J Anxiety Disord (2002) 0.81
A vascular permeability factor in lymphocyte culture supernants from patients with nephrotic syndrome. II. Pharmacological and physicochemical properties. Biomedicine (1975) 0.81
Speech pause time and the retardation rating scale for depression (ERD). Towards a reciprocal validation. J Affect Disord (1984) 0.81
Cross-cultural assessment of childhood temperament. A confirmatory factor analysis of the French Emotionality Activity and Sociability (EAS) questionnaire. Eur Child Adolesc Psychiatry (2002) 0.80
Modulation of visual event-related potentials by emotional olfactory stimuli. Neurophysiol Clin (2002) 0.80